News


Emerald Health: An Exceptional Team with a Unique Spin

March 24th, 2017 - Ryan Allway

Canada’s cannabis industry could reach $22.6 billion over the coming years, according to Deloitte, with a retail market worth up to $8.7 billion. With only around 40 producers licensed by Health Canada thus far, there’s a significant market opportunity for licensed producers to capitalize on this growth over time. Many licensed producers have already surpassed […]

Future Farm: An Emerging Leader in Cultivation & Extraction

March 22nd, 2017 - Ryan Allway

The cannabis industry is expected to reach $50 billion by 2026, according to Cowen & Co., driven by ongoing legalization initiatives throughout U.S. states. Florida’s Amendment 2 – favored by 71% of voters in November 2016 – will expand the restrictive existing medical marijuana laws and open the door to a large new market, while […]

Future Farm Acquires High Volume, State-of-the-Art Cannabis Oil Extraction Equipment

March 22nd, 2017 - Ryan Allway

Future Farm Technologies Inc. (the “Company” or “Future Farm”) (FFRMF) (FFT.CN) is pleased to announce that its majority owned subsidiary, FFM Consulting Services, LLC, has purchased a state-of-the-art extraction machine, for the manufacture of concentrated cannabis oil and purified distillate. The equipment purchased is designed to rapidly manufacture premium cannabis oil, to supply the growing […]

Lexaria Introduces TurboCBD(TM) Brand of High Absorption Full Spectrum Hemp Oil Capsules

March 22nd, 2017 - Ryan Allway

Lexaria Bioscience Corp (LXRP) (CSE:LXX)(LXX.CN) (CNSX:LXX) (the “Company” or “Lexaria”) announces the introduction of the TurboCBD™ brand of technologically enhanced, high absorption full spectrum hemp oil capsules. Lexaria’s TurboCBD™ capsules are specially formulated with the finest American Ginseng and Ginkgo Biloba for support of enhanced focus and memory, and reduced stress and fatigue. TurboCBD™ capsules […]

Maple Leaf Receives $4.8 million in Subscriptions for Private Placement

March 22nd, 2017 - Ryan Allway

Maple Leaf Green World (MGW-V) (“Maple Leaf” or the “Company“) announces it has received subscriptions for 8,783,382 units ($4,830,860) in respect of its previously announced (see the Company’s news release dated March 17, 2017 ) non-brokered private placement of up to 11,000,000 units @$0.55 ($6,000,000) . The Company is applying to the TSX Venture Exchange […]

Laguna Blends Moves to Acquire Global Cannabis Leader

March 21st, 2017 - Ryan Allway

The cannabidiol (“CBD”) industry is expected to rapidly expand into a multi-billion dollar industry over the coming years. With a growing body of research supporting its use, investors may want to take a look at both pharmaceutical and nutraceutical companies targeting the space. Hemp-based CBD producers may be particularly attractive since they are largely protected […]

InMed’s Exceptional Team Executes Ambitious Plan

March 21st, 2017 - Ryan Allway

The cannabis plant has been used for centuries for its therapeutic benefits, but researchers have only recently started to take a commercial interest in the plant. While the drug discovery process can be a billion dollar endeavor, there are some companies working on more efficient solutions to bring safe and effective cannabinoid-based drugs to market. […]

Maple Leaf Doubles Down on ACMPR License

March 21st, 2017 - Ryan Allway

Canada’s cannabis industry is expected to reach upwards of $20 billion in annual revenue over the coming years as recreational legalization is rolled out nationwide. Investors looking to capitalize on these dynamics have a limited number of opportunities with less than 40 producers licensed by Health Canada. Since most of these companies already trade with […]

Future Farm Engages CFN Media to Cultivate New Investor Audience

March 21st, 2017 - Ryan Allway

CFN Media Group (“CFN Media”, “CannabisFN”), the leading agency and digital media network dedicated to the North American cannabis industry, today announced that Future Farm Technologies Inc. (“Future Farm”) (CSE: FFT) (OTCQB: FFRMF) has engaged CFN Media to conduct a market visibility program, beginning on March 20, 2017. “We are very excited to be working […]

Maple Leaf Seeks New $6M Financing and Terminates Previous Offering

March 20th, 2017 - Ryan Allway

Maple Leaf Green World (MGW-V) (“Maple Leaf” or the “Company“) announces that it intends to raise up to CAD $6 million in capital by way of a non-brokered private placement to accredited investors. The proposed private placement consists of an offering of up to 11 million units at a subscription price of $0 .55per unit, […]

NutraFuels, Inc. (NTFU) Finalizes Product Packaging and Begins Production of Five CBD (Cannabidiol) Health & Wellness Oral Sprays Under The Company’s In House Brand NutraHempCBD For Commercial Distribution

March 16th, 2017 - Ryan Allway

COCONUT CREEK, FL–(March 16, 2017) – NutraFuels Inc. (“NutraFuels” or “NTFU”), (OTC PINK: NTFU), today announced that the company has finalized product packaging and begun production on five of the company’s latest oral spray daily health and wellness products containing industrial hemp rich CBD (Cannabidiol). The five oral spray dietary supplements support various daily health […]

Clinical Study Confirms Effectiveness of Medical Marijuana, Inc.’s RSHO

March 14th, 2017 - Ryan Allway

Cannabidiol (CBD), the main ingredient in Medical Marijuana, Inc.’s (OTC Pink: MJNA) RSHO-X, has been growing in popularity due to its tremendous potential to treat many serious medical conditions. In fact, the cannabinoid has shown promise in treating everything from arthritis to antibiotic resistant infections to schizophrenia. The non-psychoactive nature of the compound also means […]

Invictus MD Announces Completion of its Commitment to Acquire 33.33% of Licensed Producer AB Laboratories Inc.

March 14th, 2017 - Ryan Allway

VANCOUVER, March 14, 2017 /PRNewswire/ – INVICTUS MD STRATEGIES CORP. (“Invictus MD” or the “Company”) (CSE: IMH; OTC: IVITF; FRA: 8IS) is pleased to announce that it has completed its final commitment with a cash transaction of CAD$2,000,000 to acquire 33.33% of AB Laboratories Inc. (“AB Labs”), a Licensed Producer under the Access to Cannabis for […]

Maple Leaf Starts Construction Planning of its B.C. MJ Project and Updates the Use of Funds from its Previously Announced Financing

March 14th, 2017 - Ryan Allway

CALGARY , March 13, 2017/ – Maple Leaf Green World (MGW-V) (“Maple Leaf” or the “Company“) is pleased to announce that the Company’s management team and its consultant; TheraCann; a leading full service international marijuana consultancy, have recently completed a site visit of the Company’s Telkwa, B.C. greenhouse complex for the preparation of its ACMPR application […]

NutraFuels Takes a Low-Risk Approach in More Than One Way

March 13th, 2017 - Ryan Allway

The market for cannabidiol (CBD) could reach $2.1 billion by 2020, according to The Hemp Business Journal’s CBD Report, growing at 59% compound annual growth rate. With potential regulatory issues facing the recreational cannabis industry, investors may want to take a closer look at companies involved in the CBD-focused medical cannabis and nutraceutical space as […]

UPDATED: Laguna Blends to Acquire 100% Stake in a Global Cannabis Leader with Unaudited Annualized Sales of Approximately $12,000,000 USD

March 13th, 2017 - Ryan Allway

VANCOUVER, BC / March 13, 2017 / Laguna Blends Inc. (CSE:LAG) (OTC Pink: LAGBF) (Frankfurt:LB6A.F) (the “Company” or “Laguna”) is pleased to announce that it has signed a letter of Intent (LOI) to acquire 100% interest of a global Cannabis leader with unaudited annualized sales of $12,000,000 USD and adjusted EBITDA of $1,588,000 USD. This […]

Emblem Corp. Announces Retainer of Nate Nienhuis

March 13th, 2017 - Ryan Allway

Emblem Corp. (TSX VENTURE:EMC) (“Emblem” or the “Company”) is pleased to announce that it has retained the consulting services of Nate Nienhuis for its Canadian cannabis operations. “This is a major development for our Company,” said Gordon Fox, CEO of Emblem. “Mr. Nienhuis is recognized throughout North America as one of the pre-eminent experts in […]

ABcann Medicinals: Low Cost, Pharmaceutical Grade, Standardized Licensed Producer Poised to Go Public

March 9th, 2017 - Ryan Allway

Canada’s legal cannabis industry could generate $22.6 billion in annual revenue, which has created significant opportunities for investors in the space. With only 38 licensed producers to meet rising demand, investors may want to pay especially close attention to publicly-traded licensed producers that enjoy exclusive rights to grow, harvest, and distribute medical and soon recreational […]

Sessions Drama Highlights Importance of Cannabis Diversification

March 8th, 2017 - Ryan Allway

The regulatory environment surrounding medical marijuana has been complicated by President Donald Trump and his Attorney General pick Jeff Sessions. Despite recent reassurances, investors may want to take a look at diversifying their exposure to so-called “pure-play” investments with companies involved in ancillary industries that don’t necessarily touch the psychoactive components of the plant at […]

Top Ranked TSX Venture-Listed LP Eyes 32-Acre Expansion

March 8th, 2017 - Ryan Allway

  Canada’s cannabis industry could surpass $20 billion in size over the coming years with less than 40 licensed producers to meet the growing demand. While Canopy Growth Corp. (TSX: WEED) may be the most well-known licensed producers, there are many others that investors may want to consider for their portfolio. In particular, investors may […]

Vitality Biopharma Develops THC Molecule with Less Psychoactivity

March 7th, 2017 - Ryan Allway

A legal cannabis industry could surpass $50 billion in size by 2026, according to Cowen & Co., and some analysts predict the cannabinoid-based pharmaceutical industry will become a large slice of this market over time.  Emerging research suggests that cannabinoids could be helpful in treating everything from chronic pain to inflammation to neurological conditions. These […]

Why Cannabinoids Work Best Together

March 7th, 2017 - Ryan Allway

Most people can only name one or two cannabinoids, such as tetrahydrocannabinol (THC) and cannabidiol (CBD), but there are over 100 different cannabinoids within the cannabis plant. While a lot of research is focused on the effects of individual cannabinoids, emerging evidence suggests that there may be important synergies between these cannabinoids. New therapeutics that […]

Organigram: How a Misunderstood Recall Created a Buying Opportunity

March 6th, 2017 - Ryan Allway

Canada’s cannabis industry is projected to reach $22.6 billion over the coming years, according to Deloitte, which has created a significant opportunity for the 40 or so licensed producers in the space. While the industry has been rapidly growing, there have been some hiccups along the way. Some of these issues may have been large, […]

Invictus MD is Building a Portfolio of Licensed Producers with Large Production Capability

March 6th, 2017 - Ryan Allway

The global cannabis industry has taken off over the past couple of years, but the Canadian market offers the most mature opportunities. With the election of Prime Minister Justin Trudeau, the country embarked on a course to legalize recreational marijuana on a federal level and become a global leader in cannabis cultivation, processing, and export. […]

MyDx Featured in HBO’s DAILY VICE News

March 3rd, 2017 - Ryan Allway

MyDx, Inc. ( OTCQB : MYDX ), a rapidly growing science and technology company that has developed MyDx®, the first multi-use handheld chemical analyzer for consumers, announced that it was recently featured on HBO’s DAILY VICE News and will be speaking at the 3rd Annual Cannabis Business Expo to be hosted in San Diego, CA […]

True Leaf Medicine International Ltd. Announces Regulation A+ Offering

March 3rd, 2017 - Ryan Allway

True Leaf Medicine International Ltd. (CSE:MJ) (TLA.F) has filed an offering statement with the Securities and Exchange Commission to conduct a $3 million Regulation A+ securities offering in the United States and Canada. The net proceeds of this offering will be used primarily to advance True Leaf’s pet product business and conduct research on cannabis […]

Want to Start a Canna-Business? Some Ideas & Risks to Avoid

March 2nd, 2017 - Jackie Tortello

Entrepreneurs everywhere have established successful cannabis startups that not only serve customers, but act as business models for those who hope to own a cannabis company someday. While the potential for growth in this market is attractive, new companies must be mindful of legal regulations and the inherent risks associated with producing and selling marijuana […]

Vitality Biopharma Announces Proprietary THC Pharmaceutical with Greatly Decreased Psychoactivity

March 2nd, 2017 - Ryan Allway

Vitality Biopharma, Inc. ( OTCQB : VBIO ) (“Vitality” or the “Company”), a corporation dedicated to the development of cannabinoid prodrug pharmaceuticals and to unlocking the power of cannabinoids for the treatment of serious neurological and inflammatory disorders, today announced that it has created a library of proprietary glycosides of THC (delta-9-tetrahydrocannabinol), the main psychoactive […]

Singlepoint’s Low-Risk Approach to the Cannabis Industry

March 2nd, 2017 - Ryan Allway

The cannabis industry is expected to surpass $20 billion over the coming years, but investors face many risks when it comes to politics and regulation. While diversification helps address some of these concerns, investors may also want to consider companies that aren’t involved in touching the drug itself, which could insulate them from these risks. […]

Medical Marijuana Inc.’s RSHO™ Approved in Brazil for Autism

March 2nd, 2017 - Ryan Allway

Autism is the fastest growing developmental disability in the world, affecting roughly 1% of the global population and 1-in-68 U.S. children. Emerging research suggests that cannabinoids like cannabidiol (CBD) could be beneficial in alleviating the symptoms of the disease, which has led some countries to begin importing the substance as a treatment option for citizens. […]


Network Partners

Follow Us on Social Media

About CFN Media

CFN Media (CannabisFN) is the leading creative agency and media network dedicated to legal cannabis. We help marijuana businesses attract investors, customers (B2B, B2C), capital, and media visibility. Private and public marijuana companies and brands in the US and Canada rely on CFN Media to grow and succeed.

CFN launched in June of 2013 to initially serve the growing universe of publicly traded marijuana companies across North America. Today, CFN Media is also the digital media choice for the emerging brands in the space.

Learn How Your Company can Be Covered on CFN Media

Learn More About the CFN Media Sponsored Content Program

Disclaimer: Except for the historical information presented herein, matters discussed in this article contain forward-looking statements that are subject to certain risks and uncertainties that could cause actual results to differ materially from any future results, performance or achievements expressed or implied by such statements. Emerging Growth LLC dba TDM Financial, which owns CannabisFN, is not registered with any financial or securities regulatory authority, and does not provide nor claims to provide investment advice or recommendations to readers of this release. Emerging Growth LLC dba TDM Financial, which owns CannabisFN, may from time to time have a position in the securities mentioned herein and will increase or decrease such positions without notice. For making specific investment decisions, readers should seek their own advice and that of their own professional advisers. Emerging Growth LLC dba TDM Financial, which owns CannabisFN, may be compensated for its Services in the form of cash-based and/or equity- based compensation in the companies it writes about, or a combination of the two. For full disclosure please visit: http://www.cannabisfn.com/legal-disclaimer/.

Copyright © TDM Financial LLC · All Rights Reserved · Privacy Policy · Legal Disclaimer

loading